Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

Allan J. Hamilton(Arizona Science Center), Paul M. O’Byrne(Groote Schuur Hospital), Paul Stober, Richard M. Watson, Isidore Faiferman
Journal of Allergy and Clinical Immunology
August 1, 1998
Cited by 137


Related Papers